Since HSP70 acts as a chaperone for multiple oncogenic proteins, inhibition of HSP70 may also inhibit prostate cancer cell proliferation through an AR-independent mechanism, which is a hypothesis that should be further investigated in future studies. Here, HSPA1A is linked to prostate carcinoma.